PMA P100024S002

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S002
Product code
NYQ
Decision date
2012-07-31
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Approval order statement
MANUFACTURING PROCESS OF PNA OLIGOMERS IN THE DEVICE.

Current openFDA PMA Record#

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S002
Product code
NYQ
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Decision date
2012-07-31
Decision code
OK30
Date received
2012-07-11
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
MANUFACTURING PROCESS OF PNA OLIGOMERS IN THE DEVICE.